Centric Compounding Issues Nationwide Recall of Glutathione, Myer’s Cocktail, and Tri-Immune Boost Due to Elevated Endotoxin Levels

 Centric Compounding Issues Nationwide Recall of Glutathione, Myer’s Cocktail, and Tri-Immune Boost Due to Elevated Endotoxin Levels | FDA

Conference | In Person 2027 Compounding Quality Center of Excellence Annual Conference March 11 - 12, 2027

 2027 Compounding Quality Center of Excellence Annual Conference - 03/11/2027 | FDA

Arkansas Code of Rules Regarding compounding

 

Arkansas Code of Rules (.gov)

https://codeofarrules.arkansas.gov › Rules › Rule

6 days ago — 17 CAR § 160-2202, concerning good compounding practices, was repealed by Ark. R. 2026-88 (eff. June 29, 2026). For current rule, see 17 CAR § 160-2201.Read more

 

Arizona State Board of Nursing (.gov)

https://azbn.gov › news › fda-safety-advisory-compound...

6 days ago — Compounded drugs can serve an important role for patients whose medical needs cannot be met by an FDA-approved drug product.

 

• Public Notification: ZUBB Dietary Supplement may be harmful due to hidden ingredient

 Final Guidance: Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonate

 

09/01/2026	08/25/2026	Fresenius Medical Care AG & Co. KGaA	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated
09/01/2026	08/18/2026	PReye, LLC	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug
09/01/2026	08/24/2026	Peak Performance Peptides	Center for Drug Evaluation and Research (CDER)	Unapproved New Drugs/Misbranded
09/01/2026	08/18/2026	B&P Mutual Corp	Office of Inspections and Investigations	Foreign Supplier Verification Program (FSVP)
08/25/2026	07/27/2026	Vargas Produce LLC	Office of Inspections and Investigations	Foreign Supplier Verification Program (FSVP)
08/25/2026	08/14/2026	R3 Medical Companies	Center for Biologics Evaluation and Research (CBER)	Unapproved New Drugs/Unlicensed Biological Product Violations
08/18/2026	08/06/2026	Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd.	Center for Drug Evaluation and Research (CDER)	CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/Misbranded
08/18/2026	07/24/2026	Nipro Renal Solutions USA, Corporation	Center for Devices and Radiological Health	CGMP/QSR/Medical Devices/Adulterated
08/18/2026	08/12/2026	K.C. Pharmaceuticals, Inc.	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated
08/18/2026	08/13/2026	Suretec Innovations, LLC	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated and Misbranded

Showing 11 to 20 of 3,679 entries

• First
• Previous
• 1
• 2
  
  

 

09/08/2026	09/01/2026	Happy Farm Botanicals, Inc.	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated
09/08/2026	08/27/2026	Stephen J. Fallon, Ph.D.	Center for Biologics Evaluation and Research (CBER)	Bioresearch Monitoring Program/Institutional Review Board (IRB)
09/01/2026	08/24/2026	Peak Performance Peptides	Center for Drug Evaluation and Research (CDER)	Unapproved New Drugs/Misbranded
09/01/2026	08/18/2026	Reliance Life Sciences Private Limited	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated
09/01/2026	08/27/2026	Jabil Inc.	Center for Drug Evaluation and Research (CDER)	CGMP/Finished Pharmaceuticals/Adulterated
09/01/2026	08/18/2026	Shoolin Pharma Chem LLP	Center for Drug Evaluation and Research (CDER)	CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
09/01/2026	08/24/2026	Royal Peptides LLC	Center for Drug Evaluation and Research (CDER)	Unapproved New Drugs/Misbranded
09/01/2026	08/24/2026	NuScience Peptides LLC	Center for Drug Evaluation and Research (CDER)	Unapproved New Drugs/Misbranded
09/01/2026	08/24/2026	Peptide Partners LLC	Center for Drug Evaluation and Research (CDER)	Unapproved New Drugs/Misbranded
09/01/2026	08/24/2026	TXP Innovations LLC dba Tex Peptides	Center for Drug Evaluation and Research (CDER)	Unapproved New Drugs/Misbranded

Kratom Leaf

 Williamston police speak with businesses on banned substance

FDA screens GLP-! Ingredients at the Border and Warns of Vials Labeled with Pharmacies That Do Not Exist Published Sep 02, 2026 3:30 PM EDT By Dorothy Brooks

 

Medical Daily

https://www.medicaldaily.com › fda-glp1-import-alert-c...

1 day ago — DA has an import alert on GLP-1 ingredients with quality concerns and warns of fraudulent compounded semaglutide carrying false pharmacy names.